A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : EVO / Evodiamine

[Related PubMed/MEDLINE]
Total Number of Papers: 72
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   EVO  (>> Co-occurring Abbreviation)
Long Form:   Evodiamine
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2020 An Indole Alkaloid Extracted from Evodia rutaecarpa Inhibits Colonic Motility of Rats In Vitro. CCK1R, NO, SMCs
2020 BMP9 mediates the anticancer activity of evodiamine through HIF‑1alpha/p53 in human colon cancer cells. BMP9
2020 Development and in-vitro evaluation of co-loaded berberine chloride and evodiamine ethosomes for treatment of melanoma. BBR
2020 Discovery of Evodiamine Derivatives as Highly Selective PDE5 Inhibitors Targeting a Unique Allosteric Pocket. PDE5
2020 Effects of evodiamine on PI3K/Akt and MAPK/ERK signaling pathways in pancreatic cancer cells. CCK, ERK, PC, SUV, T/NT
2020 Evodiamine and rutaecarpine from Tetradium ruticarpum in the treatment of liver diseases. Rut, TCM
2020 Evodiamine attenuates adjuvant-induced arthritis in rats by inhibiting synovial inflammation and restoring the Th17/Treg balance. AA, IL-1beta
2020 Evodiamine Exerts Anticancer Effects Against 143B and MG63 Cells Through the Wnt/beta-Catenin Signaling Pathway. EMT
2020 Evodiamine has therapeutic efficacy in ulcerative colitis by increasing Lactobacillus acidophilus levels and acetate production. DSS, FMT, L. acidophilus, SCFAs, UC
10  2020 Evodiamine induces reactive oxygen species-dependent apoptosis and necroptosis in human melanoma A-375 cells. RIP, ROS
11  2020 Evodiamine inhibits proliferation and promotes apoptosis of hepatocellular carcinoma cells via the Hippo-Yes-Associated Protein signaling pathway. HCC, RT-qPCR, YAP
12  2020 Evodiamine Mitigates Cellular Growth and Promotes Apoptosis by Targeting the c-Met Pathway in Prostate Cancer Cells. Bcl-2, Bcl-xL, COX-2, CRPC, HGF, MAPK, MMP-9, NF-kappaB, siRNA, VEGF
13  2020 Evodiamine suppresses Notch3 signaling in lung tumorigenesis via direct binding to gamma-secretases. CETSA, NSCLC
14  2020 Evodiamine via targeting nNOS and AMPA receptor GluA1 inhibits nitroglycerin-induced migraine-like response. AMPA, iNOS, nNOS, NO, NTG, PAG
15  2019 Development of EGFR-targeted evodiamine nanoparticles for the treatment of colorectal cancer. CRC
16  2019 Evodiamine inactivates NF-kappaB and potentiates the antitumor effects of gemcitabine on tongue cancer both in vitro and in vivo. Bcl-2, Bcl-xL, GEM, NF-kappaB, PI
17  2019 Evodiamine inhibits migration and invasion by Sirt1-mediated post-translational modulations in colorectal cancer. CRC
18  2019 Evodiamine inhibits RANKL-induced osteoclastogenesis and prevents ovariectomy-induced bone loss in mice. BMM, PMO, RANKL
19  2019 Evodiamine prevents dextran sulfate sodium-induced murine experimental colitis via the regulation of NF-kappaB and NLRP3 inflammasome. DAI, DSS, LPS, MPO, TJ, UC, ZO-1
20  2019 Evodiamine Selectively Inhibits Multiple Myeloma Cell Growth by Triggering Activation of Intrinsic Apoptosis Pathway. MM
21  2019 Gene regulation analysis of the effects of evodiamine on tongue squamous cell carcinoma. IL, RXR, TSCC
22  2019 Protective Effects of Evodiamine against LPS-Induced Acute Kidney Injury through Regulation of ROS-NF-kappaB-Mediated Inflammation. AKI, BUN, ROS
23  2019 Thermo- and pH-responsive, Lipid-coated, Mesoporous Silica Nanoparticle-based Dual Drug Delivery System To Improve the Antitumor Effect of Hydrophobic Drugs. BBR, MSNs
24  2019 WZY-321, a novel evodiamine analog, inhibits glioma cell growth in an autophagy-associated manner. ---
25  2018 A novel microemulsion-based isotonic perfusate modulated by Ringer's solution for improved microdialysis recovery of liposoluble substances. ME, RUT
26  2018 Evodiamine activates cellular apoptosis through suppressing PI3K/AKT and activating MAPK in glioma. GBM, MMP, ROS
27  2018 Evodiamine alleviates severe pneumonia induced by methicillin-susceptible Staphylococcusaureus following cytomegalovirus reactivation through suppressing NF-kappaB and MAPKs. CMV, IL, MAPK, MSSA, NF, TNF
28  2018 Evodiamine Induces Apoptosis in SMMC-7721 and HepG2 Cells by Suppressing NOD1 Signal Pathway. Bax, Bcl-2, HCC, MAPK, NF-kappaB, NOD1
29  2018 Evodiamine Inhibits Angiotensin II-Induced Rat Cardiomyocyte Hypertrophy. ANF, Ang II, CaN, CNA, eNOS, ERK2, MKP-1, NO, NOS
30  2018 Evodiamine inhibits gastrointestinal motility via CCK and CCK1 receptor in water-avoidence stress rat model. WAS
31  2018 Evodiamine promotes differentiation and inhibits proliferation of C2C12 muscle cells. ---
32  2018 Evodiamine, a Novel NOTCH3 Methylation Stimulator, Significantly Suppresses Lung Carcinogenesis in Vitro and in Vivo. NSCLC
33  2018 Pharmacological Basis for the Use of Evodiamine in Alzheimer's Disease: Antioxidation and Antiapoptosis. AD, l-Glu
34  2017 Cytological Assessments and Transcriptome Profiling Demonstrate that Evodiamine Inhibits Growth and Induces Apoptosis in a Renal Carcinoma Cell Line. ---
35  2017 Evodiamine Inhibits Zymosan-Induced Inflammation In Vitro and In Vivo: Inactivation of NF-kappaB by Inhibiting IkappaBalpha Phosphorylation. IL-6, NF-kappaB, TNF-alpha
36  2017 Evodiamine Prevents Glioma Growth, Induces Glioblastoma Cell Apoptosis and Cell Cycle Arrest through JNK Activation. JNK, MMP, PARP
37  2016 Antiproliferative Activity and Cellular Uptake of Evodiamine and Rutaecarpine Based on 3D Tumor Models. Rut
38  2016 Effect of evodiamine and berberine on miR-429 as an oncogene in human colorectal cancer. BER, CRC
39  2016 Evodia alkaloids suppress gluconeogenesis and lipogenesis by activating the constitutive androstane receptor. CAR, FOXO1, G6Pase, hCAR, HNF4alpha, PEPCK, Rut
40  2016 Evodiamine and Its Role in Chronic Diseases. ---
41  2016 Evodiamine from Evodia rutaecarpa induces apoptosis via activation of JNK and PERK in human ovarian cancer cells. ER, MMP, p-eIF2alpha, p-PERK, PARP
42  2016 Evodiamine sensitizes BGC-823 gastric cancer cells to radiotherapy invitro and invivo. ---
43  2016 Evodiamine Suppresses ABCG2 Mediated Drug Resistance by Inhibiting p50/p65 NF-kappaB Pathway in Colorectal Cancer. ---
44  2016 MAPK pathways are involved in the inhibitory effect of berberine hydrochloride on gastric cancer MGC 803 cell proliferation and IL-8 secretion invitro and invivo. BER, MAPK
45  2016 Preparation, characterization, and anticancer efficacy of evodiamine-loaded PLGA nanoparticles. MTT
46  2016 Protein Kinase RNA-Like Endoplasmic Reticulum Kinase-Mediated Bcl-2 Protein Phosphorylation Contributes to Evodiamine-Induced Apoptosis of Human Renal Cell Carcinoma Cells. CASP, JNK, MAPK, MMP, p-Bcl-2, PARP, PI3K, RCC
47  2015 Anti-proliferative activity and cell cycle arrest induced by evodiamine on paclitaxel-sensitive and -resistant human ovarian cancer cells. ---
48  2015 Antiproliferation effect of evodiamine in human colon cancer cells is associated with IGF-1/HIF-1alpha downregulation. ---
49  2015 Evodiamine Induces Apoptosis and Inhibits Migration of HCT-116 Human Colorectal Cancer Cells. AMF, Bax, Bcl-2, CCK-8, MMP3, p-STAT3, PGI
50  2015 Evodiamine inhibits the proliferation of human osteosarcoma cells by blocking PI3K/Akt signaling. OS, PCR, PTEN
51  2015 Evodiamine, a novel inhibitor of the Wnt pathway, inhibits the self-renewal of gastric cancer stem cells. EMT, GCCs, GCSCs
52  2015 Targeting of Topoisomerase I for Prognoses and Therapeutics of Camptothecin-Resistant Ovarian Cancer. CPT, OS, TUNEL
53  2014 Activation of JNK contributes to evodiamine-induced apoptosis and G2/M arrest in human colorectal carcinoma cells: a structure-activity study of evodiamine. cyt, ERK, JNK, LDH, NAC, PARP, ROS
54  2014 Evodiamine induces G2/M arrest and apoptosis via mitochondrial and endoplasmic reticulum pathways in H446 and H1688 human small-cell lung cancer cells. NSCLC, SCLC
55  2014 Evodiamine synergizes with doxorubicin in the treatment of chemoresistant human breast cancer without inhibiting P-glycoprotein. DOX, IAPs, P-gp, PARP
56  2014 Pretreatment by evodiamine is neuroprotective in cerebral ischemia: up-regulated pAkt, pGSK3beta, down-regulated NF-kappaB expression, and ameliorated BBB permeability. ICR, pMCAO
57  2014 Supermolecular evodiamine loaded water-in-oil nanoemulsions: enhanced physicochemical and biological characteristics. NESEB
58  2014 [Inhibitory effect of norcantharidin combined with evodiamine on the growth of human hepatic carcinoma cell line HepG2 in vitro]. FCM, NCTD
59  2013 Evodiamine Induces Transient Receptor Potential Vanilloid-1-Mediated Protective Autophagy in U87-MG Astrocytes. JNK, TRPV1
60  2013 Synergistic anticancer effects of polyphyllin I and evodiamine on freshly-removed human gastric tumors. APTX, ERCC1, HDRA, PPI, Pt, TS
61  2012 Design and evaluation of a novel evodiamine-phospholipid complex for improved oral bioavailability. ---
62  2012 Pharmacokinetic comparisons of rutaecarpine and evodiamine after oral administration of Wu-Chu-Yu extracts with different purities to rats. Rut
63  2012 Transdermal behaviors comparisons among Evodia rutaecarpa extracts with different purity of evodiamine and rutaecarpine and the effect of topical formulation in vivo. EE, Rut
64  2011 Evodia rutaecarpa and Three Major Alkaloids Abrogate Influenza A Virus (H1N1)-Induced Chemokines Production and Cell Migration. DeHE, ER, Rut
65  2011 Evodiamine inhibits 12-O-tetradecanoylphorbol-13-acetate-induced activator protein 1 transactivation and cell transformation in human hepatocytes. AP-1, ERKs, TPA
66  2011 Induction of apoptosis by evodiamine involves both activation of mitotic arrest and mitotic slippage. ND
67  2010 Inhibitory effect of evodiamine alone and in combination with rosiglitazone on in vitro adipocyte differentiation and in vivo obesity related to diabetes. ROSI
68  2009 Effects of evodiamine and rutaecarpine on the secretion of corticosterone by zona fasciculata-reticularis cells in male rats. 3beta-HSD, P450scc, Rut, StAR, ZFR
69  2009 Evodiamine stabilizes topoisomerase I-DNA cleavable complex to inhibit topoisomerase I activity. TopI
70  2009 Intragastric administration of evodiamine suppresses NPY and AgRP gene expression in the hypothalamus and decreases food intake in rats. AgRP, ARC, NPY, RIA
71  2007 Anti-proliferative effects of evodiamine on human prostate cancer cell lines DU145 and PC3. ---
72  1995 Thermoregulatory effects of alkaloids isolated from Wu-chu-yu in afebrile and febrile rats. DeHE, Ta